Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 913

1.

Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits.

Gámez R, Máz R, Arruzazabala ML, Mendoza S, Castaño G.

Drugs R D. 2005;6(1):11-9.

PMID:
15806713
2.

Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.

Castaño G, Fernández L, Mas R, Illnait J, Gámez R, Mendoza S, Mesa M, Fernández J.

Drugs R D. 2005;6(4):207-19.

PMID:
16050054
4.

Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.

Castaño G, Mas R, Fernández L, Illnait J, Mesa M, Alvarez E, Lezcay M.

Drugs Aging. 2003;20(2):153-63.

PMID:
12534315
5.

Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.

Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A.

Int J Clin Pharmacol Res. 1999;19(4):105-16.

PMID:
10939028
6.

Comparison of the cholesterol-lowering effects and toxicity of D-003 and lovastatin in normocholesterolaemic rabbits.

Gámez R, Mendoza S, Mas R, Noa M, Arruzazabala L, Carbajal D, Castaño G, Goicochea E, Mesa M, Mendoza N.

Drugs R D. 2003;4(4):219-29.

PMID:
12848586
7.

Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study.

Castaño G, Arruzazabala ML, Fernández L, Mas R, Carbajal D, Molina V, Illnait J, Mendoza S, Gámez R, Mesa M, Fernández J.

Curr Ther Res Clin Exp. 2006 May;67(3):174-92. doi: 10.1016/j.curtheres.2006.06.004.

8.

Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.

Castaño G, Más R, Gámez R, Fernández L, Illnait J.

Angiology. 2004 Jul-Aug;55(4):361-71.

PMID:
15258682
9.

Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.

Castaño G, Fernández L, Mas R, Illnait J, Mesa M, Fernández JC.

Clin Drug Investig. 2003;23(10):639-50.

PMID:
17535079
10.

Concomitant use of policosanol and beta-blockers in older patients.

Castaño G, Mas R, Gámez R, Fernández J, Illnait J, Fernández L, Mendoza S, Mesa M, Gutiérrez JA, López E.

Int J Clin Pharmacol Res. 2004;24(2-3):65-77.

PMID:
15689053
11.

Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.

Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.

Int J Clin Pharmacol Res. 2002;22(3-4):89-99.

PMID:
12837046
12.

Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients.

Arruzazabala ML, Molina V, Mas R, Fernández L, Carbajal D, Valdés S, Castaño G.

Clin Exp Pharmacol Physiol. 2002 Oct;29(10):891-7.

PMID:
12207568
13.

Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.

Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.

Int J Clin Pharmacol Res. 2001;21(1):43-57.

PMID:
11708574
14.

Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia.

Castaño G, Más R, Fernández JC, Fernández L, Illnait J, López E.

Drugs R D. 2002;3(3):159-72.

PMID:
12099160
15.

[Effect of xiongshao capsule on lipid metabolism and platelet aggregation in experimental atherosclerosis rabbits].

Li LZ, Liu JG, Ma LB.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Dec;28(12):1100-3. Chinese.

PMID:
19317167
16.

Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbits.

Clubb FJ Jr, Schmitz JM, Butler MM, Buja LM, Willerson JT, Campbell WB.

Arteriosclerosis. 1989 Jul-Aug;9(4):529-37.

17.

Effects of policosanol and lovastatin in patients with intermittent claudication: a double-blind comparative pilot study.

Castaño G, Más R, Fernández L, Gámez R, Illnait J.

Angiology. 2003 Jan;54(1):25-38.

PMID:
12593493
18.

Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia.

Nordøy A, Hansen JB, Brox J, Svensson B.

Nutr Metab Cardiovasc Dis. 2001 Feb;11(1):7-16.

PMID:
11383326
19.

Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters.

Wang YW, Jones PJ, Pischel I, Fairow C.

Lipids. 2003 Feb;38(2):165-70.

PMID:
12733749
20.

Cholesterol-lowering effects of policosanol in rabbits.

Arruzazabala ML, Carbajal D, Mas R, Molina V, Valdes S, Laguna A.

Biol Res. 1994;27(3-4):205-8.

PMID:
8728832
Items per page

Supplemental Content

Write to the Help Desk